The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center is coming back to Cambridge!
NCI SBIR Development Center director Michael Weingarten, team leader Andy Kurtz, and program director Ashim Subedee will be presenting funding opportunities and other resources for startups in cancer technology. You will also learn about fifteen new targeted funding opportunities in cancer detection, diagnosis, and treatment in high priority areas of research for the NCI. Although the trends reflect improvements in cancer treatments and advances in technology have led to better tools for understanding, detecting, and diagnosing cancer, we still have work to do. In 2017, an estimated 1,688,780 new cases of cancer will be diagnosed in the United States. The NCI is poised to reduce the burden of cancer in this country and around the world at an accelerated pace.
NCI PRESENTS CURRENT AND NEW FUNDING OPPORTUNITIES
Program directors will discuss the exciting new non-dilutive targeted funding opportunities in cancer focused technology development. They will explain the application and review process at the NIH to help small businesses submit stronger applications. Additionally, the presentation will review the I-Corps at NIH program, and other initiatives run by NCI to facilitate the success of SBIR companies.
Following the presentation, selected companies will have the opportunity to meet one-on-one with NCI.